Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Self-Efficacy as a Longitudinal Predictor of Perceived Cognitive Impairment in Individuals with Multiple Sclerosis.
Early and Degressive Putamen Atrophy in Multiple Sclerosis.
Water Extract from the Leaves of Withania somnifera Protect RA Differentiated C6 and IMR-32 Cells against Glutamate-Induced Excitotoxicity.
First-dose effects of fingolimod after switching from injectable therapies in the randomized, open-label, multicenter, Evaluate Patient OutComes (EPOC) study in relapsing multiple sclerosis.
Prevalence of Incidental Narrowing of the Superior Segment of the Internal Jugular Vein in Patients Without Multiple Sclerosis.
Severe relapses under fingolimod treatment prescribed after natalizumab.
A modified superantigen rescues Ly6G(-)CD11b(+)blood monocyte suppressor function and suppresses antigen-specific inflammation in EAE.
Intrinsic and extrinsic control of oligodendrocyte development.
Fingolimod in the treatment of relapsing-remitting multiple sclerosis: long-term experience and an update on the clinical evidence.
Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis-establishing disease prognosis and monitoring patients.
Mitochondrial Complex Enzyme Activities and Cytochrome c Expression Changes in Multiple Sclerosis.
Correction to: Multiple sclerosis in the Levant: a regional consensus statement.
Tobacco smoking and excess mortality in multiple sclerosis: a cohort study.
Management of bladder dysfunction in patients with multiple sclerosis.
Fingolimod for the treatment of relapsing multiple sclerosis.
A new role for an old drug: Ambroxol triggers lysosomal exocytosis via pH-dependent Ca(2+) release from acidic Ca(2+) stores.
Multiple Sclerosis: White and Gray Matter Damage Associated with Balance Deficit Detected at Static Posturography.
Therapeutic potential of a novel cannabinoid agent CB52 in the mouse model of experimental autoimmune encephalomyelitis.
Epigenetics in NG2 glia cells.
Absence of Epstein-Barr virus in the brain and CSF of patients with multiple sclerosis.
Correction: The multiple sclerosis rating scale, revised (MSRS-R): development, refinement, and psychometric validation using an online community.
Erratum to: Genomic Binding Sites and Biological Effects of the Vitamin D-VDR Complex in Multiple Sclerosis.
Theiler's murine encephalomyelitis virus induced phenotype switch of microglia in vitro.
Nabiximols as an Agonist Replacement Therapy During Cannabis Withdrawal: A Randomized Clinical Trial.
Structure and inhibition of herpesvirus DNA packaging terminase nuclease domain.

Pages